Webinar | MedTech in China: Latest updates and top tips for market access and approvals

In this exclusive webinar “Medizintechnik in China: Neueste Updates und Top-Tipps für Marktzugang und Zulassungen” (MedTech in China: Latest updates and top tips for market access and approvals), Asia’s premier corporate service specialist Acclime and one of China’s most experienced regulatory affairs specialists Cisema jointly analyze and present the latest developments and trends for medical device registration and distribution in China.

In 2022, 69 high-risk Class III medical devices were included in the Unique Device Identification (UDI) application of the first group of devices. Recently, the National Medical Products Administration (NMPA) officially released a third batch of 103 types of class II devices which will need to have UDI labelling by June 1, 2024

Additionally, the Chinese government’s ambition that 80% of medical device expenditure must be spent through Volume-based procurement (VPB) makes it more important than ever for companies to develop a clear understanding of VPB and prepare for this increasingly new normal.

In this webinar, Cisema will discuss this latest update on the UDI database and provide a comprehensive overview of the registration process and timeline for new registration of Medical Devices in China. Furthermore, Acclime will update you on the latest VPB trends and present strategies on how companies can find success in this ever-changing and challenging market.

Lastly, we will present an ongoing success story from an international MedTech manufacturer from an early market entry study to registering their own China business and recruiting top talent for their operation.